Clinical trial
The Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose Infusion
NCT01300260 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose Infusion
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- August 31, 2011
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.